Results for: oncology+products

Bartolo Colon suspended 50 games for positive test

Bartolo Colon suspended 50 games for positive test

Bartolo Colon suspended 50 games for positive test

Pfizer earnings dip on patent expirations, taxes

CEO: Risks key for Merck to succeed, help patients

US moves to regulate e-cigarettes

Cold caps tested to prevent hair loss during chemo

Ziopharm takes bigger loss as research costs grow

Pfizer sales way off mark as company pursues AstraZeneca

AstraZeneca rejects sweetened Pfizer takeover bid

Deal fever hits global pharma sector

Stocks gain, pushing the S&P 500 to 5-year high

Pfizer's need for deal looms larger with earnings report

Merck explores $15 billion-plus drug portfolio sale - sources

Exclusive - Sanofi explores $7 billion-plus sale of drug portfolio: sources

Concerns about cancer centers under health law

Correction: Thermo Fisher-Life Technologies story

Roper will buy Managed Healthcare for $1 billion

Dendreon shares rise 4Q Provenge sales increase

Ziopharm's most advanced drug fails in study

Shake-up in pharma world as Novartis, GSK announce mega-deals

China's love and dating scene laid out on stage

Big pharma braces for M&ampA wave

Ziopharm rises on preclinical cancer therapy study

Cancer costs EU $170 bln annually

Chavez back in Venezuela, stirs succession talk

Pfizer earnings drop less than expected